Biomarker Testing in Non-Small Cell Lung Cancer

home / expert-perspective-tumor-board / biomarker-testing-in-non-small-cell-lung-cancer

Jason Porter, MD, Eric Vail, MD, and Ana Velázquez Mañana, MD, MSc, present two clinical cases of non-small cell lung cancer (NSCLC), discuss targetable genomic alterations and their approaches to biomarker testing for these patients, and touch on how socioeconomic and racial disparities may effect use of testing.